GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CARsgen Therapeutics Holdings Ltd (HKSE:02171) » Definitions » Policy Acquisition Expense

CARsgen Therapeutics Holdings (HKSE:02171) Policy Acquisition Expense


View and export this data going back to 2021. Start your Free Trial

What is CARsgen Therapeutics Holdings Policy Acquisition Expense?

Policy Acquisition Expense only applies to insurance companies.


CARsgen Therapeutics Holdings Business Description

Traded in Other Exchanges
N/A
Address
No. 466 Yindu Road, Building 2, 1st Floor, Xuhui District, Shanghai, CHN
CARsgen Therapeutics Holdings Ltd is a clinical-stage biopharmaceutical company discovering, researching, and developing cell therapies in the People's Republic of China and the United States of America.
Executives
Bei Jing Shen Nong Tou Zi Guan Li Gu Fen You Xian Gong Si 2102 Investment manager
Candock Holdings Limited 2501 Other
Yi Jie Sheng Wu Ji Shu Kong Gu You Xian Gong Si 2501 Other
Yi De Kong Gu You Xian Gong Si 2501 Other
Quan Zhou Shi Ding Wo Chuang Feng Tou Zi Zhong Xin You Xian He Huo 2501 Other
Yang Xuehong 2501 Other
Wang Huamao 2401 A concert party to an agreement to buy shares
Li Zonghai 2401 A concert party to an agreement to buy shares
Guo Bingsen 2401 A concert party to an agreement to buy shares
Accure Biotech Limited 2501 Other
Cart Biotech Limited 2501 Other
Chen Haiou 2501 Other
Guo Xiaojing 2501 Other
He Xi Holdings Limited 2501 Other
Redelle Holding Limited 2501 Other